Navigation Links
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
Date:3/17/2010

WATERLOO, Belgium, March 17, 2010 /PRNewswire/ --

- SORT OUT III Data Presented at American College of Cardiology Meeting in Atlanta and Published in the Lancet

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet. The CYPHER(R) Stent was associated with significantly lower rates of death, myocardial infarction (heart attack), and repeat revascularization (the need for another procedure) than the Endeavor(R) Stent out to 18 months. This study adds to the unmatched body of safety and efficacy data on the CYPHER(R) Stent with this comparison to the more recently approved Endeavor(R) Stent in a contemporary setting.

The large randomized trial SORT OUT III included more than 2,300 patients across a wide range of lesion and patient complexity. The investigators reported that the mortality rate (4.4% for Endeavor(R) vs. 2.7% for CYPHER(
'/>"/>

SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
2. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
3. INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
4. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
5. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
6. Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
7. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
8. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
9. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
10. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
11. Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... LAVAL, Quebec , March 27, 2015  Valeant ... announced today the closing of its previously announced registered ... States (the "Offering"). Pursuant to the Offering, ... of $199.00 per share, for aggregate gross proceeds of ... filed with the U.S. Securities and Exchange Commission a ...
(Date:3/27/2015)... Calif. , March 27, 2015 The ... life of myeloma patients while working toward prevention and ... (D-NY) for introducing a federal resolution (H. Res. ... March 2015 as "National Multiple Myeloma Awareness Month." ... with myeloma worldwide, and more than 110,000 new cases ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... SIRO Clinpharm, a global Contract Research Organization (CRO) with ... alliance with Mediscis, an early drug development company based in ... an established expert in GCP compliant early phase drug development ... all study phases for the pharmaceutical and biotech industry. ...
... 17 It is the bane of many women,s existence: fat ... commonly referred to as "bra bulge." Making matters even worse: bra ... of the body, making women go to great lengths to camouflage ... too big, or body-slimming outfits that temporarily slims them down. ...
Cached Medicine Technology:SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise 2A New Weapon In The Battle Of The Bra Bulge 2
(Date:3/29/2015)... Final Cut Pro X ... Film Studios, entitled TranSports. , “TranSports is a ... Cut Pro X,” said Christiana Austin, CEO of Pixel ... to effortlessly transition using this cool sports transition tool.” ... uniquely styled transition pack for Final Cut Pro X. ...
(Date:3/29/2015)... 29, 2015 “Health is an endo ... we learn more about the cannabinoid system … we ... Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ new on ... is celebrated. Publius, of The Cannabis Papers: A citizen’s ... of Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids ...
(Date:3/28/2015)... Coffee could not only perk you up ... gum disease, researchers have found. , They found that those ... contains antioxidants. Antioxidants fight gum disease. Does coffee, then, help ... Univ. Henry M. Goldman School of Dental Medicine explored in ... of the Journal of Periodontology. , “This is the first ...
(Date:3/28/2015)... March 28, 2015 "Necrorun" was featured ... takes a look at the latest and coolest applications ... Troohey, the host of NewsWatch and technology expert, conducted ... is an entertaining endless runner game with knights, nature, ... was released in 2009, according to Eurogamer. The popularity ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2
... Scripps Research Institute, Scripps Health, and collaborating cancer ... advanced blood test for detecting and analyzing circulating ... cancer patients. The findings, reported in five new ... provides information that may soon be comparable to ...
... (HealthDay News) -- Sometimes, there,s nothing better than scratching an ... the itch resides is key to the pleasure derived from ... might even help folks battling itchy skin ailments, according to ... Wake Forest Baptist Medical Center in Winston-Salem, N.C. The ...
... of lung cancer behave in different ways, suggesting they ... Colorado Cancer Center study published in Cancer , ... subgroups of non-small cell lung cancer (NSCLC) show distinct ... study looked at 209 patients diagnosed with stage IV ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, Feb. ... tend to eat as much or as little as their dining ... finds that women who share a meal with women they have ... at the same time. "The aim of our study was ...
... results of a multicenter study coordinated by researchers ... two investigational urine-based biomarkers are associated with prostate ... potentially life-threatening among men who take a "watchful ... Ultimately, these markers may lead to the development ...
... Mozes HealthDay Reporter , THURSDAY, Feb. 2 (HealthDay ... might play a part in determining your stroke risk, new ... may be bad for us, in terms of skin cancer ... of biostatistics at the University of Alabama at Birmingham. "But ...
Cached Medicine News:Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 2Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 3Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 4Health News:Pleasure in Scratching an Itch May Depend on Location 2Health News:New research confirms need for lung cancer testing 2Health News:If Your Dining Partner Overeats, So May You 2Health News:If Your Dining Partner Overeats, So May You 3Health News:Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting' 2Health News:Lack of Sunlight May Raise Stroke Risk 2
...
...
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
Medicine Products: